Company: SXTPW
Filing Date: 2025-06-06
Form Type: DRS
Source: 0001213900-25-052232
Chunk: 6

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-06-06
Form: DRS
Chunk 6
---
ING FORWARD-LOOKING STATEMENTS | 25 |
| USE OF PROCEEDS                                   | 25 |
| DIVIDEND POLICY                                   | 26 |
| CAPITALIZATION                                    | 26 |
| DILUTION                                          | 27 |
| DESCRIPTION OF CAPITAL STOCK                      | 28 |
| DESCRIPTION OF SECURITIES WE ARE OFFERING         | 30 |
| PLAN OF DISTRIBUTION                              | 35 |
| EXPERTS                                           | 38 |
| LEGAL MATTERS                                     | 38 |
| INCORPORATION OF CERTAIN INFORMATION BY REFERENCE | 38 |
| WHERE YOU CAN FIND MORE INFORMATION               | 39 |

You should rely only on the information contained
in this prospectus or any prospectus supplement or amendment. Neither we nor the placement agent have authorized any other person to provide
you with information that is different from, or adds to, that contained in this prospectus. If anyone provides you with different or inconsistent
information, you should not rely on it. Neither we nor the placement agent take responsibility for, and can provide no assurance as to
the reliability of, any other information that others may give you. You should assume that the information contained in this prospectus
or any free writing prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus
or of any sale of the securities. Our business, financial condition, results of operations and prospects may have changed since that date.
We are not making an offer of any securities in any jurisdiction in which such offer is unlawful.

No action is being taken in any jurisdiction outside
the United States to permit a public offering of the securities or possession or distribution of this prospectus in that jurisdiction.
Persons who come into possession of this prospectus in jurisdictions outside the United States are required to inform themselves about
and to observe any restrictions as to this offering and the distribution of this prospectus applicable to that jurisdiction.

<div align='center'>i

ABOUT THIS PROSPECTUS</div>

Throughout this prospectus, unless otherwise designated
or the context suggests otherwise,

| ● | all references to the “Company,” “60P,” the “registrant,” “we,” “our,” or “us” mean 60 Degrees Pharmaceuticals, Inc., a Delaware corporation, and majority owned subsidiary 60P Australia Pty Ltd, an Australian proprietary company limited by shares; |

| ● | all dollar or $ references, when used in this prospectus, refer to United States dollars. |